Source: CVC IN KANSAS CITY PROCEEDINGS
 August 1, 2010
By:Robert L. Hamlin, DVM, PhD, DACVIM
Cardiopulmonary interactions occur because both systems occupy space in the confined thoracic cage, because the heart pumps blood through and sucks blood from the lungs, and because the lungs hinder the flow of blood from right ventricle to left ventricle. Diseases of both systems share many signs/symptoms (e.g., cough, cyanosis, cardiomegaly, exercise intolerance) but fortunately disease of each system possesses a unique set of signs/symptoms.
 |
Source: CVC IN KANSAS CITY PROCEEDINGS
August 1, 2010
By:Kathryn M. Meurs, DVM, PhD, DACVIM
In this lecture we will discuss canine dilated (DCM) and arrhythmogenic cardiomyopathy (ARVC). We will pay particular attention to breed specific findings.
|
Source: CVC IN KANSAS CITY PROCEEDINGS
August 1, 2010
By:Kathryn M. Meurs, DVM, PhD, DACVIM
In this session we will review thoracic radiology and echocardiography with an emphasis on normal and abnormal anatomic features.
|
Source: CVC IN KANSAS CITY PROCEEDINGS
August 1, 2010
By:Kathryn M. Meurs, DVM, PhD, DACVIM
This session will focus on the three forms of feline cardiomyopathies: hypertrophic, dilated and restrictive. We will also discuss thromboembolic disease.
|
Source: CVC IN KANSAS CITY PROCEEDINGS
August 1, 2010
By:Kathryn M. Meurs, DVM, PhD, DACVIM
The objectives of this presentation will be to discuss treatment of heart disease in clinical cases.
|
Source: CVC IN KANSAS CITY PROCEEDINGS
August 1, 2010
By:Robert L. Hamlin, DVM, PhD, DACVIM
The client wants to know, and will pay for, each test you perform or each drug you give, that has a reasonable expectation of making their pet feel better or live longer.
|
Source: CVC IN BALTIMORE PROCEEDINGS
 April 1, 2010
By:Barret J. Bulmer, DVM, MS, DACVIM
The primary objectives of the cardiovascular evaluation for animals with congenital heart disease are to define the nature and severity of the anatomic defect present. Familiarity with the available therapeutic options, their efficacy and limitations is necessary before an accurate prognosis can be offered to the owner.
|
Source: CVC IN BALTIMORE PROCEEDINGS
April 1, 2010
By:Barret J. Bulmer, DVM, MS, DACVIM
Diuretics (reduction in preload), vasodilators (reduction in preload or afterload), angiotensin converting-enzyme inhibitors (reduce afterload and preload, reduce fibrosis), and positive inotropic drugs (increase contractility, may reduce regurgitant volume) all have demonstrated the capacity to lessen the severity of mitral regurgitation and dilated cardiomyopathy under certain conditions.
|
Source: CVC IN BALTIMORE PROCEEDINGS
April 1, 2010
By:Barret J. Bulmer, DVM, MS, DACVIM
The cause(s) of dilated cardiomyopathy (DCM) in dogs is (are) unknown. Some of the proposed causes of DCM include: genetic defect(s), viral infection, microvascular spasm, chemical toxin(s), dietary deficiency, and immune-mediated processes.
|
| 
